Biologics Financial Sports Medicine Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance byTim AllenMay 7, 2026
Financial SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) byWill SandbergJanuary 13, 2026
Financial OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance byJosh SandbergJanuary 12, 2026
Financial Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 byTim AllenJanuary 12, 2026
Financial Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue byJosh SandbergJanuary 9, 2026
Financial Recon Hip Replacement Implants Market is expected to generate a revenue of USD 8.44 Billion by 2032, Globally, at 3.94% CAGR: Verified Market Research® byTim AllenJanuary 8, 2026
Financial Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance byNoah SimmonsNovember 13, 2025
Financial Sports Medicine Competitor Analysis of Sports Medicine Market Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts 2024-2033 byWill SandbergNovember 11, 2025
Financial Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance byTim AllenNovember 6, 2025
Financial ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance byTim AllenOctober 31, 2025
